Jump to Content Jump to Main Navigation

Volume 9 (2011): Issue 7 (Jul 2011)

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

NCCN News

Pages: xviii–xxiv
Erratum

Pages: xxxiii
Oncology Research Program

Pages: xxxvi–xxxvii
The Fifth “C” Is Cost: Highlights From ASCO 2011

By: Harold J. Burstein

Pages: 691
Will Risk Evaluation and Mitigation Strategies Ever Be Accepted?

By: Edward C. Li

Pages: 696–699
Does Use of the Adjuvant! Model Influence Use of Adjuvant Therapy Through Better Risk Communication?

By: Jeffrey K. Belkora, David W. Hutton, Dan H. Moore and Laura A. Siminoff

Pages: 707–712
Venous Thromboembolic Disease

By: Michael B. Streiff, Paula L. Bockenstedt, Spero R. Cataland, Carolyn Chesney, Charles Eby, John Fanikos, Patrick F. Fogarty, Shuwei Gao, Julio Garcia-Aguilar, Samuel Z. Goldhaber, Hani Hassoun, Paul Hendrie, Bjorn Holmstrom, Kimberly A. Jones, Nicole Kuderer, Jason T. Lee, Michael M. Millenson, Anne T. Neff, Thomas L. Ortel, Judy L. Smith, Gary C. Yee and Anaadriana Zakarija

Pages: 714–777
Heparin-Induced Thrombocytopenia in Cancer

By: Benjamin J. Miriovsky and Thomas L. Ortel

Pages: 781–787
Risk Assessment and Prophylaxis for VTE in Cancer Patients

By: Alok A. Khorana

Pages: 789–797
Risk Stratification for Acute Pulmonary Embolism

By: Jeffrey A. Kline and David W. Miller

Pages: 800–810

Save
Email
Share
Share
Share